Compare stocks

Straumann Holding AG operates in the healthcare sector, focusing on dental and orthodontic solutions. The company specializes in developing and manufacturing dental implants, clear aligners, and digital solutions for dentists and orthodontists. Founded in 1954 and headquartered in Basel, Switzerland, Straumann has expanded its geographic footprint globally with operations in Europe, North America, Latin America, and Asia Pacific. The company's strategic positioning is supported by its strong focus on research and development, which contributes to its innovative product offerings and comprehensive digital dentistry solutions. Straumann's competitive strengths include its robust product portfolio and extensive network of professional training and support services for dental practitioners.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.